Are insulin and proinsulin independent risk markers for premature coronary artery disease?

Diabetes

Volumn 45, Issue 6, 1996, Pages 736-741

  Katz, Richard J ^a,d   Ratner, Robert E ^b   Cohen, Robert M ^c   Eisenhower, Ellen ^a   Verme, Dante ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Medlantic Research Institute   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; IMMUNOREACTIVE INSULIN; INSULIN; PROINSULIN;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIET RESTRICTION; FEMALE; HEART CATHETERIZATION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; THORAX PAIN;

EID: 0029938211     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.6.736     Document Type: Article

References (32)

1. Pyorala K, Savolainen E, Kaukola S, Haapakoski J: Plasma insulin as a coronary heart disease risk factor: relationship to other risk factors and predictive value over 9.5 year follow up of the Helsinki Policemen Study population. Acta Med Scand 701 (Suppl. ):7-14, 1985
2. Eschwege E, Richard JL, Thibult N: Coronary heart disease in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res (Suppl. ):41-46, 1985
3. Welborn TA, Wearne K: Coronary heart disease and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-160, 1979
4. Savage PJ, Saad MF: Insulin and atherosclerosis: villain, accomplice, or innocent bystander? Br Heart J 69:473-475, 1993
5. Jarrett RJ: Why is insulin not a risk factor for coronary heart disease? Diabetologia 37:940-947, 1994
6. Reaven GM, Laws A: Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 37:948-952, 1994
7. Fontbonne A: Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37:953-955, 1994
8. Stern MP: The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia 37:956-958, 1994
9. Zamboni M, Armellini F, Sheiban I, De Marchi M, Todesco T, Bergamo-Andreis IA, Cominacini L, Bosello O: Relation of body-fat distribution in men and degree of coronary artery narrowings in coronary artery disease. Am J Cardiol 70:1135-1138, 1992
10. Spallarossa P, Cordera R, Andraghetti G, Bertino G, Brunelli C, Caponnetto S: Association between plasma insulin and angiographically documented significant coronary artery disease. Am J Cardiol 74:177-179, 1994
11. Young MH, Jeng C-Y, Sheu WH, Shieh S-M, Fuh MM, Chen YI, Reaven GM: Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 72:458-460, 1993
12. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Schneider AE, Hales CN, Yudkin JS: The relationship of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin- dependent) diabetic subjects. Diabetologia 33:532-537, 1990
13. Haffner SM, Mykkanen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR: Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. Diabetes 42:1297-1302, 1993
14. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr: Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetolgia 30:698-702, 1987
15. Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkin JS, Hales CN: Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 32:689-693, 1990
16. Haffner SM, Mykkanen L, Valdez RA, Stern MP, Holloway DL, Monterrosa A, Bowsher R: Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79:1806-1810, 1994
17. Starr JI, Horowitz DL, Rubenstein AH, Mako ME: Insulin, proinsulin and C-peptide. In Methods of Hormone Radioimmunoassay. 2nd ed. Jaffe BM, Behrman HR, Eds. Orlando, FL, Academic, 1979, p. 613-642
18. Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH, Root MA, Polonsky KS, Tager HS, Rubenstein AH: Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism 35:1137-1146, 1986
19. Bowsher RR, Wolny JD, Frank BH: A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes 41:1084-1090, 1992
20. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptidc antisera. Diabetes 27:170-177, 1978
21. World Health Organization: Diabetes Melittus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
22. Stout RW, Valliance-Owen W: Insulin and atheroma. Lancet i: 1078-1080, 1969
23. Ronnemaa T, Laasko M, Pyorala K, Kallio V, Puukka P: High fasting plasma insulin is an indicator of coronary artery disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thhromb 11:80-90, 1991
24. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:154-160, 1979
25. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels. Diabetes 41:368-377, 1992
26. 125I-insulin by perfused livers from diabetic rats. J Clin Invest 57:885-896, 1976
27. Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B, Galloway J, Olefsky JM: The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 33:762-770, 1984
28. Bergenstal RM, Cohen RM, Lever E, Polonsky JB, Jaspan J, Blix P, Revers O, Kolterman J, Olefsky J, Steiner K, Cherrington A, Frank BH, Galloway J, Rubenstein AH: The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes. J Clin Endocrinol Metab 58:973-979, 1984
29. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic C-peplide in the measurement of insulin secretory rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98-105, 1986
30. Harris MI: Impaired glucose tolerance in the US population. Diabetes Care 12:464-474, 1989
31. Chauhan A, Foote J, Petch MC, Schofield PM: Hyperinsulinemia, coronary artery disease and syndrome X. J Am Coll Cardiol 23:364-368, 1994
32. Reaven GM: Syndrome X: is one enough? Am Heart J 127:1439-1442, 1994